The 2027 DCAT Global Summit — Beyond the Blueprint: Bio/Pharma’s Next Global Era — brings together a highly curated group of global leaders for an intimate executive forum focused on the structural shifts that will define pharmaceuticals in the decade ahead.
Through candid dialogue, strategic debate, and high-value networking, the Summit will explore how geopolitics, regional competitiveness, advanced therapies, digital transformation, sustainability, and new operating models are reshaping the future of the industry — redrawing how medicines get made, where capacity lives, and who controls it.
This is not another industry conference. It’s a single-track forum for 150 senior leaders, speakers, and subject-matter experts, built around the issues that keep Bio/Pharma executives up at night: which hubs will win the next decade of investment, what capacity will matter most, and how AI and new operating models are redrawing the competitive map.
